SHARE
 
Erik A. Ranheim, MD, PhD close
Erik A. Ranheim, MD, PhD

New Patients

Contact the Welcome Center for help choosing a new primary care doctor.

For Referring Physicians

How to refer a patient

Erik A. Ranheim, MD, PhD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Erik A. Ranheim, MD, PhD, earned his medical degree from the University of Minnesota and completed his residency at the Stanford University School of Medicine.

Specialties

Pathology

Clinics

University Hospital
(608) 263-8443 | (800) 323-8942 | Map

UW School of Medicine and Public Health

Department of Pathology and Laboratory Medicine

Professional Certifications and Education

Board Certification Hematopathology
Anatomic Pathology
Fellowship Stanford University School of Medicine, Stanford, CA
Residency Stanford University School of Medicine, Stanford, CA

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
PubMed Articles
Johnson KD Conn DJ Shishkova E Katsumura KR Liu P Shen S Ranheim EA Kraus SG Wang W Calvo KR Hsu AP Holland SM Coon JJ Keles S Bresnick EH Constructing and deconstructing GATA2-regulated cell fate programs to establish developmental trajectories. J Exp Med . 2020 Nov 2;217(11)
[PubMed ID: 32736380]
Wen Z Rajagopalan A Flietner E Yun G Chesi M Furumo Q Burns RT Papadas A Ranheim EA Pagenkopf AC Morrow ZT Finn R Zhou Y Li S You X Jensen JL Yu M Cicala A Menting J Mitsiades CS Callander NS Bergsagel PL Wang D Asimakopoulos F Zhang J Expression of NrasQ61R and MYC transgene in germinal center B cells induces a highly malignant multiple myeloma in mice. Blood . 2020 Jul 8;
[PubMed ID: 32640012]
Yang RK Kuznetsov IB Ranheim EA Wei JS Sindiri S Gryder BE Gangalapudi V Song YK Patel V Hank JA Zuleger C Erbe AK Morris ZS Quale R Kim K Albertini MR Khan J Sondel PM Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2. Clin Cancer Res . 2020 Jul 1;26(13):3296-3306
[PubMed ID: 32152202]
You X Chang YI Kong G Ranheim EA Zhou Y Johnson KD Mehta C Bresnick EH Zhang J Gata2 -77 enhancer regulates adult hematopoietic stem cell survival. Leukemia . 2020 Jun 27;
[PubMed ID: 32594099]
Li C Romero-Masters JC Huebner S Ohashi M Hayes M Bristol JA Nelson SE Eichelberg MR Van Sciver N Ranheim EA Scott RS Johannsen EC Kenney SC EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice. PLoS Pathog . 2020 Jun;16(6):e1008590
[PubMed ID: 32542010]
Evens AM Hong F Habermann TM Advani RH Gascoyne RD Witzig TE Quon A Ranheim EA Ansell SM Cheema PS Dy PA O'Brien TE Winter JN Cescon TP Chang JE Kahl BS A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408. Clin Cancer Res . 2020 Jun 12;
[PubMed ID: 32532790]
Romero-Masters JC Ohashi M Djavadian R Eichelberg MR Hayes M Zumwalde NA Bristol JA Nelson SE Ma S Ranheim EA Gumperz JE Johannsen EC Kenney SC An EBNA3A-Mutated Epstein-Barr Virus Retains the Capacity for Lymphomagenesis in a Cord Blood-Humanized Mouse Model. J Virol . 2020 May 4;94(10)
[PubMed ID: 32132242]
Romero-Masters JC Huebner SM Ohashi M Bristol JA Benner BE Barlow EA Turk GL Nelson SE Baiu DC Van Sciver N Ranheim EA Gumperz J Sherer NM Farrell PJ Johannsen EC Kenney SC B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection. PLoS Pathog . 2020 Feb;16(2):e1008365
[PubMed ID: 32059024]
You X Wen Z Chang YI Ranheim EA Zhou Y Zhou L Kong G Zhang J Systemic Notch downregulation promotes Kras<sup>G12D</sup> -induced myeloproliferative neoplasm. Br J Haematol . 2019 Aug;186(3):e52-e56
[PubMed ID: 30931528]
Ranheim EA A Starfish Approach to a Crisis of Dignity. WMJ . 2019 Jul;118(2):56-57
[PubMed ID: 31532927]
Erbe AK Wang W Carmichael L Hoefges A Grzywacz B Reville PK Ranheim EA Hank JA Kim K Seo S Mendonca EA Song Y Kenkre VP Hong F Gascoyne RD Paietta E Horning SJ Miller JS Kahl B Sondel PM Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab. J Immunother Cancer . 2019 Mar 12;7(1):70
[PubMed ID: 30871628]
Kong G You X Wen Z Chang YI Qian S Ranheim EA Letson C Zhang X Zhou Y Liu Y Rajagopalan A Zhang J Stieglitz E Loh M Hofmann I Yang D Zhong X Padron E Zhou L Pear WS Zhang J Downregulating Notch counteracts Kras<sup>G12D</sup>-induced ERK activation and oxidative phosphorylation in myeloproliferative neoplasm. Leukemia . 2019 Mar;33(3):671-685
[PubMed ID: 30206308]
Ranheim EA Pearls and pitfalls in the diagnostic workup of small lymph node biopsies. Mod Pathol . 2019 Jan;32(Suppl 1):38-43
[PubMed ID: 30600319]
You X Kong G Ranheim EA Yang D Zhou Y Zhang J Unique dependence on Sos1 in <i>Kras</i> <sup><i>G12D</i></sup> -induced leukemogenesis. Blood . 2018 Dec 13;132(24):2575-2579
[PubMed ID: 30377195]
Katsumura KR Mehta C Hewitt KJ Soukup AA Fraga de Andrade I Ranheim EA Johnson KD Bresnick EH Human leukemia mutations corrupt but do not abrogate GATA-2 function. Proc Natl Acad Sci U S A . 2018 Oct 23;115(43):E10109-E10118
[PubMed ID: 30301799]
Albertini MR Yang RK Ranheim EA Hank JA Zuleger CL Weber S Neuman H Hartig G Weigel T Mahvi D Henry MB Quale R McFarland T Gan J Carmichael L Kim K Loibner H Gillies SD Sondel PM Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma. Cancer Immunol Immunother . 2018 Oct;67(10):1647-1658
[PubMed ID: 30073390]
Romero-Masters JC Ohashi M Djavadian R Eichelberg MR Hayes M Bristol JA Ma S Ranheim EA Gumperz J Johannsen EC Kenney SC An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model. PLoS Pathog . 2018 Aug;14(8):e1007221
[PubMed ID: 30125329]
Mehta C Johnson KD Gao X Ong I Katsumura KR McIver SC Ranheim EA Bresnick EH Integrating Enhancer Mechanisms to Establish a Hierarchical Blood Development Program. Blood . 2017 Dec 7;130(Suppl_1):7
[PubMed ID: 31940664]
Brooks EG Thornton JM Ranheim EA Fabry Z Incorporation of autopsy case-based learning into PhD graduate education: a novel approach to bridging the "bench-to-bedside" gap. Hum Pathol . 2017 Oct;68:1-6
[PubMed ID: 28315694]
Mehta C Johnson KD Gao X Ong IM Katsumura KR McIver SC Ranheim EA Bresnick EH Integrating Enhancer Mechanisms to Establish a Hierarchical Blood Development Program. Cell Rep . 2017 Sep 19;20(12):2966-2979
[PubMed ID: 28930689]